NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today ...

Findings from a recent study suggest that the herpes virus can be modified into an effective treatment for some types of advanced melanoma. Conducte ...

Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotech innovator, announced its inclusion in an editorial by NetworkNewsWire titled“ ...

Get today's Calidi Biotherapeutics stock news. We cover the latest Calidi Biotherapeutics headlines and breaking news impacting Calidi Biotherapeutics stock performance.

Get the detailed quarterly/annual income statement for Calidi Biotherapeutics, Inc. (CLDI). Find out the revenue, expenses and profit or loss over the last fiscal year.

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary – ...

For instance, in 2016, 78 women applied to fill just four openings at Hannah’s House, a sober home on the South Side run by nonprofit CLDI, the group previously told The Billings Gazette.

CLDI Stock- Calidi Biotherapeutics raises $4.6M via discounted warrants to fund clinical programs and extend operational ...

Stay up-to-date on Calidi Biotherapeutics, Inc. Common Stock (CLDI) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq.com.

Complete Calidi Biotherapeutics Inc. stock information by Barron's. View real-time CLDI stock price and news, along with industry-best analysis.